Evidence map›Paper›PMID 38625791›Full record

ArticleCell reports2024

Endothelial cell expression of a STING gain-of-function mutation initiates pulmonary lymphocytic infiltration.

Kevin MingJie Gao, Kristy Chiang, Zhaozhao Jiang, Filiz T Korkmaz, Harish P Janardhan, Chinmay M Trivedi, Lee J Quinton, Sebastien Gingras, Katherine A Fitzgerald, Ann Marshak-Rothstein

Abstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Endothelial cell expression of STINGThe Journal of investigative dermatology · 2026
    Article
  3. Review
  4. Review
  5. Autoinflammatory syndromes of STING and TREX1 dysfunction.The Journal of clinical investigation · 2026
    Review
  6. Interstitial lung disease and the STING pathway.The Journal of clinical investigation · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. STING deletion protects against amyloid β-induced Alzheimer's disease pathogenesis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. The commoneLife · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kevin MingJie GaoDivision of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA; Division of Rheumatology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Kristy ChiangDivision of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA; Division of Rheumatology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Zhaozhao JiangDivision of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Filiz T KorkmazDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Harish P JanardhanDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Chinmay M TrivediDivision of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Lee J QuintonDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA.
Sebastien GingrasDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Katherine A FitzgeraldDivision of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA. Electronic address: kate.fitzgerald@umassmed.edu.
Ann Marshak-RothsteinDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01655, USA. Electronic address: ann.rothstein@umassmed.edu.

Funding

Medical Scientist Training at UMMS Administrative SupplementT32GM107000 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KIEFE, CATARINA I. · 2013 to 2022
$4.9M
Epigenetic regulation of lymphatic developmentR01HL141377 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TRIVEDI, CHINMAY M · 2018 to 2025
$4.1M
Regulation of Cardiac Development by Chromatin Modifying EnzymesR01HL118100 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI TRIVEDI, CHINMAY M · 2013 to 2022
$3.7M
Mechanisms of STING-driven autoinflammationR01HL165787 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Katherine A. Fitzgerald, Ann Marshak-Rothstein · 2023 to 2026
$3.3M
LOX-1 as a protective countermeasure in response to lung infectionR01HL165718 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Lee Quinton · 2023 to 2026
$3.0M
Regulation of Lupus by Cytosolic DNA SensorsR01AI128358 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., MARSHAK-ROTHSTEIN, ANN · 2017 to 2021
$2.7M
Immunological Mechanisms in Systemic Autoimmune DiseaseR01AR055634 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MARSHAK-ROTHSTEIN, ANN · 2008 to 2012
$1.8M
Training in the Molecular Basis of Autoimmunity and AutoinflammationT32AI132152 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Katherine A. Fitzgerald, Ann Marshak-Rothstein · 2018 to 2026
$1.6M
Radioresistant Innate Immunity in SAVI Tissue-Specific AutoinflammationR21AI178978 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., MARSHAK-ROTHSTEIN, ANN · 2023 to 2024
$461k
Establishing Mechanisms of LOX-1-Dependent Immune Regulation During PneumoniaK99HL159258 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KORKMAZ, FILIZ · 2022 to 2023
$213k
Investigating the role of B cells in pulmonary fibrosis resulting from STING gain-of-function autoinflammationF30HL154674 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAO, KEVIN MINGJIE · 2020 to 2022
$114k
NHLBI NIH HHS F30 HL154674NHLBI NIH HHS K99 HL159258NHLBI NIH HHS R01 HL118100NHLBI NIH HHS R01 HL141377NHLBI NIH HHS R01 HL165718NHLBI NIH HHS R01 HL165787NIAID NIH HHS R01 AI128358NIAID NIH HHS R21 AI178978NIAID NIH HHS T32 AI132152NIAMS NIH HHS R01 AR055634NIGMS NIH HHS T32 GM107000
6 · The paper itself

Abstract

Patients afflicted with Stimulator of interferon gene (STING) gain-of-function mutations frequently present with debilitating interstitial lung disease (ILD) that is recapitulated in mice expressing the STING

Indexed as

Endothelial CellsGain of Function MutationLungMembrane ProteinsAnimalsHumansLung Diseases, InterstitialLymphocytesMiceMice, Inbred C57BLSTING ProteinMembrane ProteinsSting1 protein, mouseSTING Proteinautoinflammationbronchus-associated lymphoid tissueconditional knockinCP: Immunologyendothelial cellsinnate immunityinterstitial lung diseaseSAVISTINGstromal cell immunity

Identifiers

PMID38625791
PMCPMC11108094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.